Capricor Therapeutics Inc (CAPR)
18.58
-0.87
(-4.47%)
USD |
NASDAQ |
Nov 04, 16:00
18.75
+0.17
(+0.91%)
Pre-Market: 08:42
Capricor Therapeutics Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.0087 |
| December 31, 2020 | 0.0113 |
| September 30, 2020 | 0.0105 |
| June 30, 2020 | 0.0101 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -3.315 |
| June 30, 2017 | -2.149 |
| March 31, 2017 | -1.934 |
| December 31, 2016 | -3.474 |
| September 30, 2016 | 283.04 |
| June 30, 2016 | -2.376 |
| March 31, 2016 | -9.378 |
| December 31, 2015 | -8.874 |
| September 30, 2015 | 4.755 |
| June 30, 2015 | 2.01 |
| March 31, 2015 | 1.25 |
| December 31, 2014 | -1.465 |
| September 30, 2014 | -2.047 |
| June 30, 2014 | -2.802 |
| March 31, 2014 | -2.387 |
| December 31, 2013 | -7.407 |
| September 30, 2013 | -0.2085 |
| June 30, 2013 | -0.2097 |
| March 31, 2013 | -0.2972 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.0113
Maximum
Dec 2020
0.0021
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.3764 |
| ResMed Inc | 0.1304 |
| enVVeno Medical Corp | -- |
| Regenxbio Inc | 0.00 |
| AIM ImmunoTech Inc | 0.4322 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 38.28M |
| Total Liabilities (Quarterly) | 26.78M |
| Shareholders Equity (Quarterly) | 11.50M |
| Current Ratio | 1.372 |